Composition
- Active ingredients
- SUNITINIB MALATE EQ 12.5MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- SUNITINIB MALATE EQ 50MG BASE · CapsuleNDA021938-003 · Prescription
- SUNITINIB MALATE EQ 12.5MG BASE · CapsuleNDA021938-001 · Prescription
- SUNITINIB MALATE EQ 37.5MG BASE · CapsuleNDA021938-004 · Prescription
- SUNITINIB MALATE EQ 25MG BASE · CapsuleNDA021938-002 · Prescription
- SUNITINIB MALATE EQ 50MG BASE · CapsuleNDA021968-003 · Prescription
- SUNITINIB MALATE EQ 12.5MG BASE · CapsuleThis page
- SUNITINIB MALATE EQ 25MG BASE · CapsuleNDA021968-002 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021968.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Sutent
- Active substance
- sunitinib malate
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Cppi CV
- Status
- Prescription
- FDA approval
- 26 Jan 2006
- Application
- NDA021968-001